Docaravimab/Miromavimab

ๅคšๅฏ็‘ž้Ÿฆๅ•ๆŠ—/่ฟˆๆด›้Ÿฆๅ•ๆŠ—

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDocaravimab/Miromavimab
Drug Alias NameๆŠ—็‹‚็Šฌ็—…ๅ•ๅ…‹้š†ๆŠ—ไฝ“Rabies mAbAnti-rabies monoclonal antibodyAnti-rabies monoclonal antibody cocktailRabimabs +[9]ย 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionRabies virus neutralization
TargetsRabies virus
Therapy Area/IndicationsRabies
Global Approved IndicationsRabies
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2019/09/03
Country/TerritoryIndia
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsRabies
Inactive IndicationsN/A

Other Information

ATC CodeL01XC
Related LinksN/A